Cargando…

Down-Regulation of Colonic ACE2 Expression in Patients With Inflammatory Bowel Disease Responding to Anti-TNF Therapy: Implications for COVID-19

Background and Aims: Angiotensin-converting enzyme II (ACE2) is the key molecule for understanding the pathophysiology of COVID-19. The risk of COVID-19 and impact of immunosuppressive treatment on disease course in patients with inflammatory bowel disease (IBD) remain controversial. We aimed to det...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiao-Zhi, Qiu, Yun, Jeffery, Louisa, Liu, Fen, Feng, Rui, He, Jin-Shen, Tan, Jin-Yu, Ye, Zi-Yin, Lin, Si-Nan, Ghosh, Subrata, Iacucci, Marietta, Chen, Min-Hu, Mao, Ren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835139/ https://www.ncbi.nlm.nih.gov/pubmed/33511147 http://dx.doi.org/10.3389/fmed.2020.613475

Ejemplares similares

New endoscopic tools in inflammatory bowel disease
por: Nardone, Olga Maria, et al.
Publicado: (2022)

Diverse Immune Effects of Bovine Colostrum and Benefits in Human Health and Disease
por: Ghosh, Subrata, et al.
Publicado: (2021)

Can advanced endoscopic techniques for assessment of mucosal inflammation and healing approximate histology in inflammatory bowel disease?
por: Nardone, Olga Maria, et al.
Publicado: (2019)

Inflammatory bowel disease-related colorectal cancer: Past, present and future perspectives
por: Majumder, Snehali, et al.
Publicado: (2022)

Prevalence and Anatomic Distribution of Serrated and Adenomatous Lesions in Patients with Inflammatory Bowel Disease
por: Lee, Lik Hang, et al.
Publicado: (2017)

Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period
por: Iacucci, Marietta, et al.
Publicado: (2020)

Blockade of IL-23: What is in the Pipeline?
por: Parigi, Tommaso Lorenzo, et al.
Publicado: (2022)

Emotional state should not be used to differentiate IBD from IBS – Authors' reply
por: Iacucci, Marietta, et al.
Publicado: (2020)

Immune checkpoint inhibitor-associated gastrointestinal and hepatic adverse events and their management
por: Shivaji, Uday N., et al.
Publicado: (2019)

Fr497 INCIDENCE AND OUTCOMES OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD): A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Khan, Shahab R., et al.
Publicado: (2021)

High definition i-SCAN endoscopy with water immersion technique accurately reflects histological severity of celiac disease
por: Iacucci, Marietta, et al.
Publicado: (2016)

Next-Generation Endoscopy in Inflammatory Bowel Disease
por: Zammarchi, Irene, et al.
Publicado: (2023)

High-definition-iSCAN virtual chromoendoscopy has high sensitivity and specificity for the diagnosis of eosinophilic esophagitis
por: Gregory, Eustace, et al.
Publicado: (2017)

Tests that now deserve to be more widely adopted in IBD clinical practice
por: Labarile, Nunzia, et al.
Publicado: (2020)

Inflammation-Driven Colorectal Cancer Associated with Colitis: From Pathogenesis to Changing Therapy
por: Nardone, Olga Maria, et al.
Publicado: (2023)

Involvement of digestive system in COVID-19: manifestations, pathology, management and challenges
por: Su, Song, et al.
Publicado: (2020)

Raman spectroscopy accurately differentiates mucosal healing from non-healing and biochemical changes following biological therapy in inflammatory bowel disease
por: Smith, Samuel C. L., et al.
Publicado: (2021)

Ultra-high Magnification Endocytoscopy and Molecular Markers for Defining Endoscopic and Histologic Remission in Ulcerative Colitis—An Exploratory Study to Define Deep Remission
por: Iacucci, Marietta, et al.
Publicado: (2021)

Real‐world use of endoscopic and histological indices in ulcerative colitis: Results of a global survey
por: Nardone, Olga Maria, et al.
Publicado: (2023)

Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis
por: Mao, Ren, et al.
Publicado: (2020)

Whole Transcription Profile of Responders to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease
por: Salvador-Martín, Sara, et al.
Publicado: (2021)

The hospitalization burden of inflammatory bowel disease in China: a nationwide study from 2013 to 2018
por: He, Yi-Ming, et al.
Publicado: (2022)

Technological advances in inflammatory bowel disease endoscopy and histology
por: Alfarone, Ludovico, et al.
Publicado: (2022)

Impact of COVID-19 on the Healthcare of Patients With Inflammatory Bowel Disease: A Comparison Between Epicenter vs. Non-epicenter Areas
por: Qiu, Yun, et al.
Publicado: (2020)

Computer-Aided Imaging Analysis of Probe-Based Confocal Laser Endomicroscopy With Molecular Labeling and Gene Expression Identifies Markers of Response to Biological Therapy in IBD Patients: The Endo-Omics Study
por: Iacucci, Marietta, et al.
Publicado: (2022)

Training methods in optical diagnosis and characterization of colorectal polyps: a systematic review and meta-analysis
por: Smith, Samuel C.L., et al.
Publicado: (2021)

Clinical outcomes, predictors of prognosis and health economics consequences in IBD patients after discontinuation of the first biological therapy
por: Shivaji, Uday N., et al.
Publicado: (2020)

Advanced technology for assessment of endoscopic and histological activity in ulcerative colitis: a systematic review and meta-analysis
por: Nardone, Olga Maria, et al.
Publicado: (2022)

ACE Inhibitor-Induced Angioedema of the Bowel
por: Campbell, Tabitha, et al.
Publicado: (2010)

A minimal physiologically based pharmacokinetic model to characterize colon TNF suppression and treatment effects of an anti-TNF monoclonal antibody in a mouse inflammatory bowel disease model
por: Zheng, Songmao, et al.
Publicado: (2020)

Engineered soluble ACE2 receptor: Responding to change with change
por: Li, Guangyao, et al.
Publicado: (2023)

Inflammatory Bowel Disease: A Global Disease
por: Ghosh, Subrata, et al.
Publicado: (2013)

Cost per responder of TNF-α therapies in Germany
por: Gissel, Christian, et al.
Publicado: (2013)

The Impact of COVID-19 on Gastrointestinal Endoscopy Training in the United Kingdom
por: Siau, Keith, et al.
Publicado: (2020)

Linking Genotype with Phenotype in Inflammatory Bowel Disease – Will We Ever Have Reagent Standard Patients?
por: Ghosh, Subrata
Publicado: (2000)

Anti-TNF Withdrawal in Inflammatory Bowel Disease
por: Torres, Joana, et al.
Publicado: (2016)

ACE/ACE2 balance might be instrumental to explain the certain comorbidities leading to severe COVID-19 cases
por: Bank, Sarbashri, et al.
Publicado: (2021)

Reduced expression of COVID-19 host receptor, ACE2 is associated with small bowel inflammation, more severe disease, and response to anti-TNF therapy in Crohn’s disease
por: Potdar, Alka A., et al.
Publicado: (2020)

Clinical Significance of Colonic Diverticulosis Associated with Bowel Symptoms and Colon Polyp
por: Lee, Kang-Moon, et al.
Publicado: (2010)

Role of angiotensin-converting enzyme (ACE) and ACE2 in a rat model of smoke inhalation induced acute respiratory distress syndrome
por: Yilin, Zhao, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_nstphkeod0k9qpmsni6oqev67c